TOKYO, Jan. 17, 2025 /PRNewswire/ — GOLFIN, the pioneering Web3-based Golf2Earn platform, has been announced as the official sponsor of Web3 Hub Davos 2025. The event, taking place from January 20–23, 2025, in Davos, Switzerland, runs alongside the World Economic Forum’s Annual Meeting and will highlight the latest advancements in Web3, blockchain, and decentralized technologies across industries. Golfin is set to showcase how Web3 technology is reshaping the future of golf.
Golfin’s Key Highlights at Web3 Hub Davos 2025:
Golfin’s Approach to Web3 Golf:
Enhancing Golf Through Innovation: Golfin revolutionizes the golf experience by allowing players to earn points through real-world gameplay on verified golf courses. These points can be used to enhance their digital gameplay, creating a seamless connection between physical activity and in-game progression. Additionally, players can collect exclusive in-game items and trade NFTs, adding value and depth to both their golfing and gaming experiences.
Vision for the Future:
Golfin is committed to transforming the traditional golf industry by integrating Web3 technology to create a more immersive and accessible golfing experience. By fostering strategic partnerships and engaging global decision-makers, Golfin plans to expand its ecosystem and drive innovation in both the sports and blockchain sectors.
About Golfin GPS: The Golfin GPS app connects real golf with digital gameplay. Players earn points while playing at certified golf courses.
For More Information: golfin.io & web3hubdavos.com .
Join the Movement: Stay updated and join Golfin’s Web3 revolution by visiting the official website or following on Twitter (JP), Twitter (Global), Discord, Instagram, & Linktree.
Photo – https://mma.prnewswire.com/media/2600611/Davos_Post_02.jpg
View original content:https://www.prnewswire.co.uk/news-releases/golfin-to-showcase-web3-innovation-at-web3-hub-davos-2025-302354177.html
SHANGHAI, April 26, 2025 /PRNewswire/ -- On April 23, under the spotlight at 2025 Shanghai…
April 26, 2025 10:00 ET | Source: Protara Therapeutics TARA-002 demonstrates 100% complete response rate…
NEW YORK, April 26, 2025 (GLOBE NEWSWIRE) -- The fitness and bodybuilding industry is constantly…
LOS ANGELES, April 26, 2025 (GLOBE NEWSWIRE) -- Prime Biome is a rigorously developed herbal…
GEN-1013 was studied in an aggressive CT26 murine cancer model using both IT and IV…
Norcross, Georgia, April 26, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: Why belly…